CAR-T therapy is creating new possibilities for patients with B-cell non-Hodgkin lymphoma (NHL). But as treatment options expand, pharmacists are being asked to navigate more than the latest clinical evidence.
You may be helping your team evaluate new therapies, update protocols, coordinate treatment, educate patients, manage toxicities, or prepare for new approaches to CAR-T delivery.
Staying current helps you make those decisions with greater confidence and keep your team prepared for what’s next.
What’s Changing in CAR-T Therapy?
CD19-directed CAR-T therapies are now an important treatment option across diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL), and mantle cell lymphoma (MCL).
And the landscape continues to move quickly.
Outpatient delivery models are expanding. New CAR-T constructs and dual-targeting therapies are emerging. Efforts to shorten vein-to-vein time and improve T-cell persistence may further change how these therapies are delivered.
For pharmacists, understanding these developments isn’t just about knowing what’s new. It’s about knowing what they mean for your patients, your team, and your practice.
Where Your Expertise Makes a Difference
As CAR-T therapy becomes more complex, your role can help make the treatment process safer, more coordinated, and easier for patients and care teams to navigate.
That may mean helping your team:
- Make informed treatment decisions by applying updated evidence and guidelines across NHL subtypes.
- Prepare for new therapies by evaluating formulary considerations, product differences, protocols, and operational requirements.
- Educate patients with confidence about lymphodepletion, infusion, monitoring, potential toxicities, and what to expect throughout treatment.
- Strengthen safety practices for cytokine release syndrome (CRS), neurotoxicity, and other treatment-related concerns.
- Improve coordination among referring providers, treatment centers, pharmacists, and other members of the care team.
The more quickly CAR-T evolves, the more valuable it becomes to understand both the evidence and how to put it into practice.
Get Practical Guidance You Can Use
You don’t have to sort through the changing CAR-T landscape on your own.
The FREE Pharmacy Consults activity, Coordinating Transformative Care in NHL: Insights for Delivering CAR-T Therapy in the Era of Expanded Access and Therapeutic Innovation, brings expert pharmacists together for case-based discussions focused on the decisions and challenges you may encounter in practice.
You’ll explore how to:
- Apply current evidence and guidelines for established and emerging CAR-T therapies in DLBCL, FL, and MCL
- Contribute to treatment planning and team-based protocols
- Improve coordination throughout the CAR-T process
- Strengthen patient and staff education
- Support safety management and therapeutic surveillance
- Prepare your practice for emerging CAR-T therapies and delivery models
Instead of simply reviewing what’s changing, you’ll hear practical perspectives on what those changes mean for pharmacy practice and patient care.
Be Ready for the Next CAR-T Decision
Whether you’re directly involved in CAR-T therapy today or preparing for a growing role in cellular therapy, staying current can help you contribute more confidently when your team and your patients need your expertise.
The training is free. Take the course and gain practical strategies you can bring back to your practice.